===== phenotype 41=================================================================
proportion of pts: 0.169377231257
lambda: 18146.7307051
----------------------------------------
Diseases of esophagus, stomach, and duodenum	0.121
Hypertensive disease	0.102
Range name na	0.091
Disorders of the eye and adnexa	0.089
Disorders of lipoid metabolism	0.081
Other symptoms involving abdomen and pelvis	0.076
Arthropathies and related disorders	0.069
Other diseases of intestines and peritoneum	0.067
Other diseases of urinary system	0.060
Rheumatism, excluding the back	0.052
General symptoms	0.051
Diseases of the ear and mastoid process	0.050
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.047
Symptoms involving urinary system	0.046
----------------------------------------
Antihypertensive Agents	0.063
Anti-Ulcer Agents	0.061
Proton Pump Inhibitors	0.058
Histamine H1 Antagonists, Non-Sedating	0.052
Antioxidants	0.052
Anti-Inflammatory Agents, Non-Steroidal	0.052
Cardiotonic Agents	0.052
Sympatholytics	0.050
Anti-Allergic Agents	0.050
Cyclooxygenase Inhibitors	0.050
Anti-Arrhythmia Agents	0.049
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.048
Adrenergic beta-1 Receptor Antagonists	0.048
Angiotensin-Converting Enzyme Inhibitors	0.048
Antipyretics	0.048
Anticholesteremic Agents	0.045
Vitamins	0.045
Platelet Aggregation Inhibitors	0.043
Vasodilator Agents	0.042
Fibrinolytic Agents	0.042
===== phenotype 47=================================================================
proportion of pts: 0.167393891313
lambda: 18134.8534216
----------------------------------------
Hypertensive disease	0.119
Ischemic heart disease	0.116
Disorders of lipoid metabolism	0.115
Diabetes	0.075
Symptoms involving respiratory system and other chest symptoms	0.074
Symptoms involving skin and other integumentary tissue	0.074
Other diseases of the upper respiratory tract	0.072
Other forms of heart disease	0.071
Organic sleep disorders	0.065
Acute respiratory infections	0.065
Drug dependence	0.056
Dorsopathies	0.052
Symptoms involving cardiovascular system	0.046
----------------------------------------
Diuretics	0.065
Sympatholytics	0.058
Adrenergic beta-1 Receptor Antagonists	0.058
Anti-Arrhythmia Agents	0.057
Antihypertensive Agents	0.054
Fibrinolytic Agents	0.053
Vasodilator Agents	0.052
Platelet Aggregation Inhibitors	0.052
Sodium Potassium Chloride Symporter Inhibitors	0.051
Antipyretics	0.050
Anti-Inflammatory Agents, Non-Steroidal	0.050
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.049
Cyclooxygenase Inhibitors	0.049
Anti-Allergic Agents	0.045
Calcium Channel Blockers	0.044
Anticholesteremic Agents	0.044
Angiotensin-Converting Enzyme Inhibitors	0.043
Sodium Chloride Symporter Inhibitors	0.042
Anti-Inflammatory Agents	0.042
Hypoglycemic Agents	0.041
===== phenotype 33=================================================================
proportion of pts: 0.155493851646
lambda: 17361.7456823
----------------------------------------
Diabetes	0.127
Hypertensive disease	0.108
Disorders of lipoid metabolism	0.097
Disorders of the eye and adnexa	0.080
Symptoms involving respiratory system and other chest symptoms	0.064
Acute respiratory infections	0.064
Range name na	0.061
Gout	0.060
Chronic obstructive pulmonary disease and allied conditions	0.055
Diseases of male genital organs	0.054
Ischemic heart disease	0.050
Diseases of esophagus, stomach, and duodenum	0.049
Rheumatism, excluding the back	0.048
Nephritis, nephrotic syndrome, and nephrosis	0.042
General symptoms	0.040
----------------------------------------
Hypoglycemic Agents	0.070
Cardiotonic Agents	0.063
Adrenergic alpha-1 Receptor Antagonists	0.061
Vasodilator Agents	0.060
Gout Suppressants	0.056
Hypolipidemic Agents	0.056
Anti-Bacterial Agents	0.055
Angiotensin-Converting Enzyme Inhibitors	0.054
Antihypertensive Agents	0.053
Calcium Channel Blockers	0.052
Tocolytic Agents	0.050
Antipyretics	0.050
Anti-Inflammatory Agents, Non-Steroidal	0.049
Cyclooxygenase Inhibitors	0.048
Platelet Aggregation Inhibitors	0.046
Fibrinolytic Agents	0.046
Anticholesteremic Agents	0.045
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.045
Anti-Arrhythmia Agents	0.043
===== phenotype 22=================================================================
proportion of pts: 0.155890519635
lambda: 16093.2263163
----------------------------------------
Ischemic heart disease	0.159
Disorders of lipoid metabolism	0.141
Hypertensive disease	0.125
Symptoms involving respiratory system and other chest symptoms	0.086
Arthropathies and related disorders	0.080
Range name na	0.079
Disorders of the eye and adnexa	0.066
Other forms of heart disease	0.064
Organic sleep disorders	0.058
Diseases of the ear and mastoid process	0.051
Nonspecific findings on examination of blood	0.049
Rheumatism, excluding the back	0.043
----------------------------------------
Anticholesteremic Agents	0.077
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.076
Hypolipidemic Agents	0.067
Platelet Aggregation Inhibitors	0.064
Fibrinolytic Agents	0.063
Cyclooxygenase Inhibitors	0.062
Anti-Inflammatory Agents, Non-Steroidal	0.062
Antihypertensive Agents	0.060
Antipyretics	0.059
Cardiotonic Agents	0.057
Angiotensin-Converting Enzyme Inhibitors	0.054
Explosive Agents	0.054
Vasodilator Agents	0.053
Sodium Chloride Symporter Inhibitors	0.051
Anti-Ulcer Agents	0.050
Proton Pump Inhibitors	0.049
Diuretics	0.043
===== phenotype 46=================================================================
proportion of pts: 0.164220547402
lambda: 15928.9977633
----------------------------------------
Hypertensive disease	0.115
Disorders of lipoid metabolism	0.107
Range name na	0.103
Ischemic heart disease	0.102
Other forms of heart disease	0.093
General symptoms	0.084
Diseases of male genital organs	0.062
Symptoms involving respiratory system and other chest symptoms	0.060
Disorders of thyroid gland	0.051
Dorsopathies	0.048
Disorders of the eye and adnexa	0.048
Rheumatism, excluding the back	0.043
Symptoms involving urinary system	0.042
Nonspecific findings on examination of blood	0.041
----------------------------------------
Antioxidants	0.093
Sympatholytics	0.079
Vitamin B Complex	0.075
Adrenergic beta-1 Receptor Antagonists	0.072
Vitamins	0.071
Adrenergic alpha-1 Receptor Antagonists	0.071
Platelet Aggregation Inhibitors	0.063
Fibrinolytic Agents	0.061
Anti-Arrhythmia Agents	0.060
Antipyretics	0.058
Anti-Inflammatory Agents, Non-Steroidal	0.058
Cyclooxygenase Inhibitors	0.058
Antihypertensive Agents	0.054
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.045
Diuretics	0.042
Angiotensin-Converting Enzyme Inhibitors	0.040
===== phenotype 6=================================================================
proportion of pts: 0.138040460135
lambda: 15915.8266357
----------------------------------------
Range name na	0.112
Hypertensive disease	0.108
Disorders of lipoid metabolism	0.101
General symptoms	0.080
Symptoms involving respiratory system and other chest symptoms	0.079
Dorsopathies	0.077
Other forms of heart disease	0.066
Anemias	0.065
Na	0.058
Disorders of the peripheral nervous system	0.053
Other diseases of respiratory system	0.053
Disorders of the eye and adnexa	0.050
Symptoms involving cardiovascular system	0.049
Organic sleep disorders	0.047
----------------------------------------
Anticonvulsants	0.070
Anti-Anxiety Agents	0.069
GABA Modulators	0.068
Analgesics	0.068
Serotonin Uptake Inhibitors	0.066
Histamine H1 Antagonists	0.064
Antiparkinson Agents	0.064
Hypnotics and Sedatives	0.062
Antidepressive Agents, Second-Generation	0.061
Antiemetics	0.060
Excitatory Amino Acid Antagonists	0.060
Antimanic Agents	0.057
Antidepressive Agents	0.051
Analgesics, Opioid	0.048
Narcotics	0.046
Antipsychotic Agents	0.045
Calcium Channel Blockers	0.041
===== phenotype 18=================================================================
proportion of pts: 0.166997223324
lambda: 15674.0678714
----------------------------------------
Diabetes	0.149
Disorders of lipoid metabolism	0.126
Hypertensive disease	0.121
Nutritional deficiencies	0.099
Arthropathies and related disorders	0.092
Range name na	0.087
Disorders of the peripheral nervous system	0.086
Rheumatism, excluding the back	0.084
Organic sleep disorders	0.058
General symptoms	0.054
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.043
----------------------------------------
Hypoglycemic Agents	0.085
Vitamin B Complex	0.074
Vitamins	0.066
Antioxidants	0.066
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.065
Antihypertensive Agents	0.061
Anticholesteremic Agents	0.059
Sodium Chloride Symporter Inhibitors	0.059
Diuretics	0.059
Bone Density Conservation Agents	0.056
Anti-Inflammatory Agents, Non-Steroidal	0.055
Immunosuppressive Agents	0.054
Hypolipidemic Agents	0.053
Cyclooxygenase Inhibitors	0.053
Anti-Arrhythmia Agents	0.047
Antipyretics	0.045
Platelet Aggregation Inhibitors	0.044
===== phenotype 30=================================================================
proportion of pts: 0.146370487902
lambda: 15575.5517826
----------------------------------------
Diseases of veins and lymphatics, and other diseases of circulatory system	0.086
Other forms of heart disease	0.084
Symptoms involving respiratory system and other chest symptoms	0.084
Disorders of lipoid metabolism	0.083
Hypertensive disease	0.082
Diseases of esophagus, stomach, and duodenum	0.070
General symptoms	0.069
Range name na	0.068
Overweight, obesity and other hyperalimentation	0.063
Anemias	0.061
Dorsopathies	0.052
Rheumatism, excluding the back	0.052
Diabetes	0.050
Arthropathies and related disorders	0.049
Symptoms involving cardiovascular system	0.045
----------------------------------------
Anticoagulants	0.073
Adrenergic beta-1 Receptor Antagonists	0.072
Proton Pump Inhibitors	0.072
Anti-Ulcer Agents	0.072
Sympatholytics	0.068
Diuretics	0.066
Rodenticides	0.063
Vasodilator Agents	0.060
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.060
Sodium Potassium Chloride Symporter Inhibitors	0.060
Anticholesteremic Agents	0.060
Anti-Arrhythmia Agents	0.059
Analgesics, Non-Narcotic	0.059
Hypolipidemic Agents	0.056
Antihypertensive Agents	0.051
Calcium Channel Blockers	0.047
===== phenotype 39=================================================================
proportion of pts: 0.156287187624
lambda: 15455.7494412
----------------------------------------
General symptoms	0.088
Symptoms involving respiratory system and other chest symptoms	0.082
Diseases of arteries, arterioles, and capillaries	0.079
Hypertensive disease	0.077
Symptoms involving skin and other integumentary tissue	0.066
Rheumatism, excluding the back	0.061
Other diseases of intestines and peritoneum	0.061
Anemias	0.058
Other symptoms involving abdomen and pelvis	0.055
Range name na	0.051
Disorders of fluid, electrolyte, and acid-base balance	0.050
Other disorders of female genital tract	0.049
Disorders of thyroid gland	0.049
Disorders of the peripheral nervous system	0.046
Symptoms involving urinary system	0.045
Nonspecific findings on examination of urine	0.043
Disorders of breast	0.041
----------------------------------------
Platelet Aggregation Inhibitors	0.066
Antipyretics	0.064
Fibrinolytic Agents	0.064
Cyclooxygenase Inhibitors	0.064
Anti-Inflammatory Agents, Non-Steroidal	0.063
Antihypertensive Agents	0.063
Diuretics	0.062
Vasodilator Agents	0.059
Analgesics, Non-Narcotic	0.057
Calcium Channel Blockers	0.055
Sympatholytics	0.055
Adrenergic beta-1 Receptor Antagonists	0.052
Anti-Arrhythmia Agents	0.051
Sodium Chloride Symporter Inhibitors	0.048
Anti-Bacterial Agents	0.045
Vitamins	0.045
Proton Pump Inhibitors	0.045
Anticholesteremic Agents	0.041
===== phenotype 7=================================================================
proportion of pts: 0.159063863546
lambda: 15053.6255927
----------------------------------------
Acute respiratory infections	0.160
Hypertensive disease	0.127
Disorders of lipoid metabolism	0.122
Symptoms involving respiratory system and other chest symptoms	0.101
General symptoms	0.090
Other diseases of the upper respiratory tract	0.084
Disorders of thyroid gland	0.077
Range name na	0.066
Other diseases of skin and subcutaneous tissue	0.063
Symptoms involving head and neck	0.057
Nutritional deficiencies	0.053
----------------------------------------
Anti-Allergic Agents	0.071
Bronchodilator Agents	0.069
Anti-Inflammatory Agents	0.063
Histamine H1 Antagonists, Non-Sedating	0.062
Antihypertensive Agents	0.062
Anti-Inflammatory Agents, Non-Steroidal	0.058
Anticholesteremic Agents	0.057
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.057
Cyclooxygenase Inhibitors	0.056
Antipyretics	0.053
Platelet Aggregation Inhibitors	0.052
Anti-Bacterial Agents	0.052
Fibrinolytic Agents	0.052
Dermatologic Agents	0.051
Hypolipidemic Agents	0.051
Vasodilator Agents	0.047
Anti-Ulcer Agents	0.044
Proton Pump Inhibitors	0.042
===== phenotype 44=================================================================
proportion of pts: 0.13962713209
lambda: 15043.0571898
----------------------------------------
Chronic obstructive pulmonary disease and allied conditions	0.165
Symptoms involving respiratory system and other chest symptoms	0.105
Hypertensive disease	0.089
Disorders of lipoid metabolism	0.075
Ischemic heart disease	0.069
Other diseases of respiratory system	0.061
Pneumonia and influenza	0.061
Range name na	0.059
Other forms of heart disease	0.052
Arthropathies and related disorders	0.052
Diseases of esophagus, stomach, and duodenum	0.045
Diseases of the ear and mastoid process	0.043
Anemias	0.043
Other diseases of the upper respiratory tract	0.041
Diabetes	0.041
----------------------------------------
Adrenergic beta-2 Receptor Agonists	0.107
Tocolytic Agents	0.104
Bronchodilator Agents	0.088
Glucocorticoids	0.087
Anti-Ulcer Agents	0.066
Proton Pump Inhibitors	0.065
Anti-Inflammatory Agents	0.059
Cholinergic Antagonists	0.056
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.052
Anticholesteremic Agents	0.050
Antipyretics	0.047
Fibrinolytic Agents	0.046
Platelet Aggregation Inhibitors	0.044
Antihypertensive Agents	0.044
Anti-Inflammatory Agents, Non-Steroidal	0.043
Cyclooxygenase Inhibitors	0.043
===== phenotype 25=================================================================
proportion of pts: 0.153510511702
lambda: 14986.6555191
----------------------------------------
Range name na	0.117
Hypertensive disease	0.104
Other forms of heart disease	0.096
Disorders of lipoid metabolism	0.094
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.079
Disorders of the eye and adnexa	0.071
Symptoms involving respiratory system and other chest symptoms	0.066
General symptoms	0.063
Disorders of thyroid gland	0.060
Symptoms involving urinary system	0.055
Diseases of veins and lymphatics, and other diseases of circulatory system	0.054
Cerebrovascular disease	0.050
Symptoms involving skin and other integumentary tissue	0.048
Operations on the musculoskeletal system	0.043
----------------------------------------
Bone Density Conservation Agents	0.091
Vitamins	0.077
Vasodilator Agents	0.066
Antihypertensive Agents	0.064
Diuretics	0.063
Hypolipidemic Agents	0.062
Anticholesteremic Agents	0.060
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.058
Sodium Chloride Symporter Inhibitors	0.058
Anti-Inflammatory Agents, Non-Steroidal	0.055
Fibrinolytic Agents	0.055
Cyclooxygenase Inhibitors	0.054
Antipyretics	0.052
Calcium Channel Blockers	0.052
Platelet Aggregation Inhibitors	0.050
Angiotensin-Converting Enzyme Inhibitors	0.041
Anti-Arrhythmia Agents	0.041
===== phenotype 35=================================================================
proportion of pts: 0.150337167791
lambda: 14872.1422322
----------------------------------------
Dorsopathies	0.111
Hypertensive disease	0.104
Disorders of lipoid metabolism	0.095
Arthropathies and related disorders	0.091
Symptoms involving skin and other integumentary tissue	0.089
Nonspecific findings on examination of blood	0.087
Rheumatism, excluding the back	0.078
Other diseases of urinary system	0.077
Symptoms involving urinary system	0.061
Sprains and strains of joints and adjacent muscles	0.061
Certain traumatic complications and unspecified injuries	0.055
Acute respiratory infections	0.048
Diseases of male genital organs	0.044
----------------------------------------
Antihypertensive Agents	0.065
Angiotensin II Type 1 Receptor Blockers	0.061
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.057
Anticholesteremic Agents	0.057
Anti-Inflammatory Agents, Non-Steroidal	0.056
Cyclooxygenase Inhibitors	0.055
Antipyretics	0.054
Platelet Aggregation Inhibitors	0.053
Anti-Inflammatory Agents	0.050
Anti-Arrhythmia Agents	0.050
Fibrinolytic Agents	0.048
Bronchodilator Agents	0.047
Sympatholytics	0.047
Hypolipidemic Agents	0.045
Anti-Allergic Agents	0.044
Adrenergic beta-1 Receptor Antagonists	0.044
Proton Pump Inhibitors	0.042
Anti-Ulcer Agents	0.042
Serotonin Uptake Inhibitors	0.042
Diuretics	0.041
===== phenotype 2=================================================================
proportion of pts: 0.142800476002
lambda: 14786.7325407
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.156
Mycoses	0.138
Other inflammatory conditions of skin and subcutaneous tissue	0.085
Hypertensive disease	0.075
Diabetes	0.070
Malignant neoplasm of skin	0.069
Disorders of the eye and adnexa	0.069
Disorders of lipoid metabolism	0.060
Neoplasm of uncertain behavior of other sites & tissues	0.060
Dorsopathies	0.057
Rheumatism, excluding the back	0.056
Range name na	0.054
Acute respiratory infections	0.052
----------------------------------------
Antifungal Agents	0.073
Antihypertensive Agents	0.064
Fibrinolytic Agents	0.064
Platelet Aggregation Inhibitors	0.063
Anti-Inflammatory Agents, Non-Steroidal	0.061
Cyclooxygenase Inhibitors	0.060
Antipyretics	0.060
Anticholesteremic Agents	0.059
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.057
Vasodilator Agents	0.047
Hypolipidemic Agents	0.047
Angiotensin-Converting Enzyme Inhibitors	0.045
Calcium Channel Blockers	0.045
Anti-Inflammatory Agents	0.044
Hypoglycemic Agents	0.044
Proton Pump Inhibitors	0.043
Anti-Arrhythmia Agents	0.042
Anti-Bacterial Agents	0.042
Diuretics	0.042
===== phenotype 31=================================================================
proportion of pts: 0.151130503768
lambda: 13977.868131
----------------------------------------
Diabetes	0.141
Nephritis, nephrotic syndrome, and nephrosis	0.095
Hypertensive disease	0.090
Diseases of other endocrine glands	0.082
Disorders of lipoid metabolism	0.078
Anemias	0.077
Disorders of fluid, electrolyte, and acid-base balance	0.074
Range name na	0.071
Other forms of heart disease	0.070
Symptoms involving respiratory system and other chest symptoms	0.062
Disorders of the eye and adnexa	0.061
Cerebrovascular disease	0.057
Operations on the nose, mouth, and pharynx	0.042
----------------------------------------
Hypoglycemic Agents	0.071
Diuretics	0.063
Cardiotonic Agents	0.062
Antihypertensive Agents	0.061
Anti-Allergic Agents	0.056
Vasodilator Agents	0.054
Sympatholytics	0.054
Sodium Chloride Symporter Inhibitors	0.053
Bronchodilator Agents	0.053
Angiotensin-Converting Enzyme Inhibitors	0.053
Anti-Inflammatory Agents	0.051
Calcium Channel Blockers	0.050
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.050
Anti-Ulcer Agents	0.047
Anticholesteremic Agents	0.047
Proton Pump Inhibitors	0.046
Anti-Arrhythmia Agents	0.046
Antipyretics	0.043
Platelet Aggregation Inhibitors	0.041
===== phenotype 5=================================================================
proportion of pts: 0.16501388338
lambda: 13843.0424376
----------------------------------------
Arthropathies and related disorders	0.135
Hypertensive disease	0.127
Other diseases of skin and subcutaneous tissue	0.111
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.094
Disorders of lipoid metabolism	0.091
Diseases of esophagus, stomach, and duodenum	0.080
Infections of skin and subcutaneous tissue	0.078
Other diseases of urinary system	0.062
Rheumatism, excluding the back	0.060
Diseases of the ear and mastoid process	0.059
Other diseases of the upper respiratory tract	0.057
Diseases of male genital organs	0.045
----------------------------------------
Anti-Inflammatory Agents, Non-Steroidal	0.069
Cyclooxygenase Inhibitors	0.068
Fibrinolytic Agents	0.068
Platelet Aggregation Inhibitors	0.066
Antipyretics	0.066
Antihypertensive Agents	0.062
Anti-Arrhythmia Agents	0.055
Vitamins	0.053
Bone Density Conservation Agents	0.053
Vasodilator Agents	0.052
Calcium Channel Blockers	0.050
Anti-Ulcer Agents	0.050
Proton Pump Inhibitors	0.049
Adrenergic beta-1 Receptor Antagonists	0.049
Sympatholytics	0.048
Antimalarials	0.048
Hypnotics and Sedatives	0.048
Analgesics, Non-Narcotic	0.047
===== phenotype 13=================================================================
proportion of pts: 0.147163823879
lambda: 13731.1989615
----------------------------------------
Hypertensive disease	0.110
Dorsopathies	0.086
Na	0.081
Disorders of lipoid metabolism	0.077
Rheumatism, excluding the back	0.076
Arthropathies and related disorders	0.072
Range name na	0.070
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.064
Neurotic, personality, nonpsychotic disorders	0.062
Nutritional deficiencies	0.059
Symptoms involving head and neck	0.056
Organic sleep disorders	0.054
Anemias	0.051
Disorders of the eye and adnexa	0.043
Malignant neoplasm of breast	0.041
----------------------------------------
Bone Density Conservation Agents	0.079
Antidepressive Agents, Second-Generation	0.076
Vitamins	0.075
Serotonin Uptake Inhibitors	0.072
Hypnotics and Sedatives	0.068
Bronchodilator Agents	0.061
GABA Modulators	0.061
Analgesics, Non-Narcotic	0.059
Proton Pump Inhibitors	0.055
Anti-Allergic Agents	0.054
Antihypertensive Agents	0.054
Anti-Inflammatory Agents	0.053
Dermatologic Agents	0.052
Vasodilator Agents	0.051
Calcium Channel Blockers	0.045
Anti-Anxiety Agents	0.044
Antipyretics	0.042
===== phenotype 32=================================================================
proportion of pts: 0.156287187624
lambda: 13667.3891736
----------------------------------------
Dorsopathies	0.129
Hypertensive disease	0.125
Range name na	0.109
Arthropathies and related disorders	0.105
Other diseases of urinary system	0.093
Symptoms involving respiratory system and other chest symptoms	0.091
Rheumatism, excluding the back	0.089
General symptoms	0.081
Symptoms involving urinary system	0.074
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.056
Other symptoms involving abdomen and pelvis	0.048
----------------------------------------
Topoisomerase II Inhibitors	0.081
Antidepressive Agents, Tricyclic	0.081
Bone Density Conservation Agents	0.081
Antiemetics	0.079
Anti-Bacterial Agents	0.073
Muscle Relaxants, Central	0.071
Anti-Infective Agents, Urinary	0.070
Vitamins	0.066
Analgesics, Opioid	0.065
Angiotensin-Converting Enzyme Inhibitors	0.064
Narcotics	0.061
Diuretics	0.061
Analgesics, Non-Narcotic	0.057
Tranquilizing Agents	0.050
Anti-Allergic Agents	0.042
===== phenotype 28=================================================================
proportion of pts: 0.164220547402
lambda: 13603.9239825
----------------------------------------
Arthropathies and related disorders	0.160
Dorsopathies	0.137
Rheumatism, excluding the back	0.121
Hypertensive disease	0.106
Disorders of thyroid gland	0.101
Range name na	0.083
Disorders of lipoid metabolism	0.068
General symptoms	0.067
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.059
Acute respiratory infections	0.051
Disorders of the eye and adnexa	0.046
----------------------------------------
Calcium Channel Blockers	0.075
Glucocorticoids	0.074
Voltage-Gated Sodium Channel Blockers	0.067
Enzyme Inhibitors	0.065
Anti-Inflammatory Agents	0.064
Anticonvulsants	0.063
Analgesics	0.062
Vasodilator Agents	0.056
Antihypertensive Agents	0.055
Anti-Arrhythmia Agents	0.055
Anti-Inflammatory Agents, Non-Steroidal	0.050
Anti-Anxiety Agents	0.050
Cyclooxygenase Inhibitors	0.046
Immunosuppressive Agents	0.046
Dermatologic Agents	0.045
Anti-Ulcer Agents	0.043
Antirheumatic Agents	0.042
Serotonin Uptake Inhibitors	0.042
===== phenotype 45=================================================================
proportion of pts: 0.137643792146
lambda: 13317.7836878
----------------------------------------
Hypertensive disease	0.135
Disorders of lipoid metabolism	0.118
Range name na	0.098
Ischemic heart disease	0.082
Other forms of heart disease	0.068
Other diseases of skin and subcutaneous tissue	0.067
Arthropathies and related disorders	0.065
Diseases of arteries, arterioles, and capillaries	0.057
Symptoms involving respiratory system and other chest symptoms	0.055
General symptoms	0.053
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.052
Disorders of the eye and adnexa	0.052
Neoplasm of uncertain behavior of other sites & tissues	0.049
Disorders of thyroid gland	0.048
----------------------------------------
Enzyme Inhibitors	0.089
Immunosuppressive Agents	0.078
Cardiotonic Agents	0.074
Dermatologic Agents	0.073
Antirheumatic Agents	0.072
Antimetabolites, Antineoplastic	0.072
Vitamin B Complex	0.066
Nucleic Acid Synthesis Inhibitors	0.065
Folic Acid Antagonists	0.065
Abortifacient Agents, Nonsteroidal	0.060
Angiotensin-Converting Enzyme Inhibitors	0.056
Sympatholytics	0.052
Adrenergic beta-1 Receptor Antagonists	0.050
Antihypertensive Agents	0.044
Platelet Aggregation Inhibitors	0.042
Antipyretics	0.042
===== phenotype 38=================================================================
proportion of pts: 0.146767155891
lambda: 12813.7113182
----------------------------------------
Other diseases of the upper respiratory tract	0.109
Hypertensive disease	0.100
Arthropathies and related disorders	0.076
Range name na	0.073
Disorders of lipoid metabolism	0.072
Symptoms involving respiratory system and other chest symptoms	0.070
Diabetes	0.069
Rheumatism, excluding the back	0.067
Disorders of the eye and adnexa	0.065
Chronic obstructive pulmonary disease and allied conditions	0.064
Other forms of heart disease	0.053
Overweight, obesity and other hyperalimentation	0.052
Diseases of esophagus, stomach, and duodenum	0.046
Organic sleep disorders	0.042
Disorders of the peripheral nervous system	0.041
----------------------------------------
Histamine H1 Antagonists, Non-Sedating	0.103
Bronchodilator Agents	0.102
Anti-Allergic Agents	0.101
Dermatologic Agents	0.094
Anti-Inflammatory Agents	0.071
Anti-Asthmatic Agents	0.071
Enzyme Inhibitors	0.067
Vasodilator Agents	0.064
Calcium Channel Blockers	0.052
Anti-Inflammatory Agents, Non-Steroidal	0.050
Antihypertensive Agents	0.050
Cyclooxygenase Inhibitors	0.047
Vasoconstrictor Agents	0.045
Antipyretics	0.043
Immunosuppressive Agents	0.041
===== phenotype 3=================================================================
proportion of pts: 0.103133677112
lambda: 12736.6955118
----------------------------------------
Miscellaneous diagnostic and therapeutic procedures	0.120
Operations on the cardiovascular system	0.109
Ischemic heart disease	0.095
Operations on the musculoskeletal system	0.075
Hypertensive disease	0.067
Other forms of heart disease	0.065
Range name na	0.062
Diseases of arteries, arterioles, and capillaries	0.061
Complications of surgical and medical care, not elsewhere classified	0.060
Symptoms involving respiratory system and other chest symptoms	0.057
Drug dependence	0.048
Arthropathies and related disorders	0.046
